Sovran Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$406K Sell
970
-220
-18% -$93K 0.03% 418
2026
Q1
$517K Sell
1,190
-12
-1% -$6.04K 0.04% 361
2025
Q4
$582K Sell
1,202
-1,076
-47% -$500K 0.05% 315
2025
Q3
$1.06M Buy
2,278
+22
+1% +$8.53K 0.09% 209
2025
Q2
$852K Sell
2,256
-962
-30% -$347K 0.09% 230
2025
Q1
$1.08M Sell
3,218
-18
-0.6% -$5.79K 0.14% 162
2024
Q4
$990K Buy
+3,236
New +$1.13M 0.14% 153

Other funds holding HCA

Sovran Advisors's HCA Position: Q2 2026 in Review

Sovran Advisors reduced its HCA Healthcare (HCA) stake by 18% in Q2 2026, selling an estimated $93K and leaving 970 shares worth $406K. The position accounts for 0.03% of the portfolio, ranked #418.

Sovran Advisors first reported a position in HCA in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.08M in Q1 2025. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Sovran Advisors held 970 shares of HCA Healthcare worth $406K as of Q2 2026.
  • Sovran Advisors sold 220 HCA Healthcare shares in Q2 2026, an estimated $93K.
  • HCA Healthcare made up 0.03% of Sovran Advisors's portfolio in Q2 2026, its #418 holding.
  • Sovran Advisors first reported a position in HCA Healthcare in Q4 2024 and has held it in 7 quarters since.
  • Sovran Advisors's HCA Healthcare position peaked at $1.08M in Q1 2025.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Sovran Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.